Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies.
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Emily Zevon, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Division on Engineering and Physical Sciences, Committee on Applied and Theoretical Statistics, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Emily Zevon, Erin Balogh